Skip to main content

Press releases View all 16 hits

Vironova awarded funding to advance expertise in artificial intelligence and machine learning for future healthcare

Vironova awarded funding to advance expertise in artificial intelligence and machine learning for future healthcare

Press releases   •   Nov 21, 2017 11:16 CET

Vironova has been awarded funding for a two-year project on Artificial Intelligence (AI) and Machine Learning for future healthcare applications. The project is part of a joint initiative by VINNOVA, Formas and the Swedish Energy Agency, in collaboration with Huddinge University Hospital and Uppsala University Hospital, adding to our already front-line expertise in applying AI to image analysis.

Vironova is part of major effort to advance Sweden’s position in biological drugs

Vironova is part of major effort to advance Sweden’s position in biological drugs

Press releases   •   Jul 10, 2017 08:43 CEST

Vironova’s expertise makes us perfectly placed to participate in a major effort for development of biological drugs - recently presented by Vinnova and the Swedish Research Council. Biological structures are complex to work with; the manufacturing process must ensure product quality and needs to be monitored with many analytical methods such as Vironova’s MiniTEM system.

Vironova AB and AstraZeneca are partners in FoRmulaEx, a new Industrial Research Centre receiving 75Million SEK from SSF to work on key development bottlenecks for powerful new medicines

Vironova AB and AstraZeneca are partners in FoRmulaEx, a new Industrial Research Centre receiving 75Million SEK from SSF to work on key development bottlenecks for powerful new medicines

Press releases   •   Jul 06, 2017 11:10 CEST

As previously reported on www.vironova.com, Vironova AB, AstraZeneca, Camurus AB and key research groups headed up by Chalmers University of technology, have teamed up in the FoRmulaEx centre, a new multi-disciplinary Industrial Research Centre that has recently received funding of 75M SEK from the Swedish foundation for Strategic Research (SSF). The focus is on complex, oligonucleotide drugs.

Vironova awarded a key US patent for further automation of transmission electron microscopy

Vironova awarded a key US patent for further automation of transmission electron microscopy

Press releases   •   Apr 21, 2017 09:59 CEST

Vironova has recently been granted a US patent with the title " A method for automatic correction of astigmatism.” The method removes a tedious manual step that requires considerable operator skill. It can be applied to any electron microscope, allowing for automated correction of the electron beam and ultimately enabling fully automated image acquisition.

News 1 hit

Events View all 9 hits

Reveal information that Gives Insights –  New Approaches to Sub-Visible Particle Characterization

Reveal information that Gives Insights – New Approaches to Sub-Visible Particle Characterization

Events   •   Sep 06, 2016 14:44 CEST

Speakers: Dr. Josefina Nilsson, Head of EM services and Dr. Gustaf Kylberg, Product Manager MiniTEM, Vironova AB Abstract: A case study on how to speed up time to insight during purification and formulation development. The purity of two different Adenovirus samples were compared and analyzed. Automated image acquisition and particle classification was performed using MiniTEMTM -a comp...

Oct 04 - Oct 07

Boston Convention and Exhibition Center, Boston, MA

Vironova is sponsoring the 2nd Annual Formulation & Drug Delivery Congress, 18-19 May 2016.

Vironova is sponsoring the 2nd Annual Formulation & Drug Delivery Congress, 18-19 May 2016.

Events   •   Feb 12, 2016 13:21 CET

The event provides a unique opportunity for over 150 formulation and drug delivery leaders to network and engage in scientific discussions about the most exciting areas of research that will shape the future landscape of the industry. Vironova scientist Dr. Mathieu Colomb-Delsuc will hold an oral presentation; "Fast and Efficient Characterization of Drug Carriers by Electron Microscopy".

May 18 - May 19

Kensington Close Hotel in London, UK.

MRS Fall Meeting & Exhibit 2015 – one of the most innovative trade shows

MRS Fall Meeting & Exhibit 2015 – one of the most innovative trade shows

Events   •   Sep 02, 2015 13:05 CEST

MRS Fall Meeting & Exhibit is one of the most innovative trade shows in science and technologies. The show will offer insight into; Thermal processing equipment; Electronic and electrical properties instruments; Deposition equipment, processes and materials; Materials characterization equipment; Optical components and equipment and Microscopes, electron microscopy. http://www.mrs.org/fal...

Nov 29 - Dec 04

Hynes Convention Center 900 Boylston St, Boston, MA 02115, Boston, USA

Bio Europe 2015 – Building value through partnerships

Bio Europe 2015 – Building value through partnerships

Events   •   Sep 02, 2015 12:55 CEST

BIO-Europe® is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry. http://www.ebdgroup.com/bioeurope/index.php

Nov 02 - Nov 04

International Congress Center (ICM) Messe Muenchen GmbH Fairgrounds, 81823 Munich, Germany

Images 2 hits

Vironova MiniTEM event

Vironova MiniTEM event

License Creative Commons Attribution
Download
Size

759 KB • 1400 x 933 px

Vironova MiniTEM event desktop

Vironova MiniTEM event de...

License Creative Commons Attribution
Download
Size

1.12 MB • 1400 x 2100 px

Documents 2 hits

Vironova Awards

Vironova Awards

Documents   •   Aug 31, 2015 15:07 CEST

Vironovas Research and Development has lead to a large number of acknowledgements, both for the company and for MR Homman's leadership and innovations.

Vironova in Agrifack No 3 – 2008

Vironova in Agrifack No 3 – 2008

Documents   •   Jun 10, 2008 14:00 CEST

Nu är det kvinnornas tur att göra karriär. Vinnova står bakom en satsning som bygger på ett utbyte mellan universitet och näringsliv. Ida-Maria Sintorn vid forskningsföretaget Vironova får tillgång till ny kunskap och nätverk med andra forskare. - Tack vare stödet från Vinnova har jag en fot i både akademin och industrin.